Therapeutic Effects of Zymomonas mobilis on Experimental DSS-Induced Colitis Mouse Model
- PMID: 38004805
- PMCID: PMC10672878
- DOI: 10.3390/microorganisms11112793
Therapeutic Effects of Zymomonas mobilis on Experimental DSS-Induced Colitis Mouse Model
Abstract
Zymomonas mobilis, a Gram-negative bacteria observed in some popular beverages, is considered safe and has been studied for its potential therapeutic benefits. In this study, we explored its effects on the inflammatory process, tissue integrity, differential gene expression, and microbiota composition in an experimental dextran sulfate sodium (DSS)-induced colitis model in mice. As a result, Z. mobilis alleviated the symptoms caused by DSS administration, as indicated by reduced weight loss, disease activity index, a significant reduction in the colon weight/length ratio, and histopathological improvement. Also, Z. mobilis could restore the mucosal barrier as well as increase the expression of Muc3 and Ocln genes. An analysis of 16S rRNA sequences showed that Z. mobilis alters gut microbiota, increasing Akkermansia muciniphila abundance and decreasing Escherichia coli. Furthermore, Z. mobilis seems to be involved in potentiating a regulatory phenotype by inducing immunomodulatory genes like Tgfb, Il5, Il10, and Foxp3 and reducing the relative mRNA expression of proinflammatory cytokines TNF, Il6, and Il17. Our data suggest that Z. mobilis could alleviate disease progression and be considered a possible probiotic adjuvant for pathologies of the bowel.
Keywords: DSS-induced colitis; Zymomonas mobilis; immunomodulation; microbiota; probiotics.
Conflict of interest statement
The authors declare no conflict of interest.
Figures






Similar articles
-
Administration of Akkermansia muciniphila Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice.Front Microbiol. 2019 Oct 1;10:2259. doi: 10.3389/fmicb.2019.02259. eCollection 2019. Front Microbiol. 2019. PMID: 31632373 Free PMC article.
-
Pediococcus pentosaceus CECT 8330 protects DSS-induced colitis and regulates the intestinal microbiota and immune responses in mice.J Transl Med. 2022 Jan 15;20(1):33. doi: 10.1186/s12967-022-03235-8. J Transl Med. 2022. PMID: 35033121 Free PMC article.
-
A β-N-acetylhexosaminidase Amuc_2109 from Akkermansia muciniphila protects against dextran sulfate sodium-induced colitis in mice by enhancing intestinal barrier and modulating gut microbiota.Food Funct. 2022 Feb 21;13(4):2216-2227. doi: 10.1039/d1fo04094d. Food Funct. 2022. PMID: 35133390
-
Sustained ameliorative effect of Lactobacillus acidophilus LA85 on dextran sulfate sodium-induced colitis in mice.J Food Sci. 2023 Sep;88(9):3893-3904. doi: 10.1111/1750-3841.16723. Epub 2023 Aug 7. J Food Sci. 2023. PMID: 37548631
-
Metformin Exerts Anti-inflammatory and Mucus Barrier Protective Effects by Enriching Akkermansia muciniphila in Mice With Ulcerative Colitis.Front Pharmacol. 2021 Sep 30;12:726707. doi: 10.3389/fphar.2021.726707. eCollection 2021. Front Pharmacol. 2021. PMID: 34658866 Free PMC article.
References
-
- de Azerêdo G.A., Stamford T.L.M., de Souza E.L., Veras F.F., de Almeida E.R., de Araújo J.M. In Vivo Assessment of Possible Probiotic Properties of Zymomonas Mobilis in a Wistar Rat Model. Electron. J. Biotechnol. 2010;13:3–4. doi: 10.2225/vol13-issue2-fulltext-4. - DOI
-
- Tallyne de Aguiar Silva A., Lima Cavalcanti I.D., Ayanny de Lima Fernandes M., Gisele de Oliveira Coimbra C., Manoella de Souza Lima G. Effect of Zymomonas Mobilis Probiotic on Cholesterol and Its Lipoprotein Fractions and the Intestinal Regulation. Clin. Nutr. 2020;39:3750–3755. doi: 10.1016/j.clnu.2020.04.002. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous